United States · FDA National Drug Code directory

Viokace

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 73562-208_95ece3e2-a51f-4f4c-81ec-71aa2930a158
Product NDC: 73562-208
Form: TABLET
Composition / generic term: Pancrelipase
Labeler: Aimmune Therapeutics, Inc.
Marketing category: BLA
Marketing start / end (source format): 20210301
Source listing expiry: 20261231

Source-listed ingredients

PANCRELIPASE LIPASE — 20880 [USP'U]/1
PANCRELIPASE PROTEASE — 78300 [USP'U]/1
PANCRELIPASE AMYLASE — 78300 [USP'U]/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BOTTLE in 1 CARTON (73562-208-10) / 100 TABLET in 1 BOTTLE · 73562-208-10

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →